Azelastine Drug Interactions: 342 Major, 290 Moderate
Azelastine Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Azelastine. Always confirm against the full prescribing information.
100 interactions
Abatacept
The metabolism of Azelastine can be increased when combined with Abatacept.
Level 1 evidence
Acebutolol
The metabolism of Acebutolol can be decreased when combined with Azelastine.
Level 2 evidence
Acenocoumarol
The metabolism of Acenocoumarol can be decreased when combined with Azelastine.
Level 2 evidence
Acetaminophen
The metabolism of Azelastine can be decreased when combined with Acetaminophen.
Level 2 evidence
Acoramidis
The metabolism of Azelastine can be decreased when combined with Acoramidis.
Level 2 evidence
Acyclovir
The metabolism of Azelastine can be decreased when combined with Acyclovir.
Level 2 evidence
Adagrasib
The metabolism of Azelastine can be decreased when combined with Adagrasib.
Level 2 evidence
Adalimumab
The metabolism of Azelastine can be increased when combined with Adalimumab.
Level 1 evidence
Alpelisib
The serum concentration of Azelastine can be decreased when it is combined with Alpelisib.
Level 2 evidence
Aminophylline
The metabolism of Aminophylline can be decreased when combined with Azelastine.
Level 2 evidence
Amlodipine
The metabolism of Azelastine can be decreased when combined with Amlodipine.
Level 2 evidence
Amphetamine
Amphetamine may decrease the sedative activities of Azelastine.
Level 1 evidence
Enter your NPI to unlock 39 major interactions for Azelastine
Azelastine has 767 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Azelastine has 342 major, 290 moderate, and 135 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Azelastine. Always confirm against the full prescribing information.